Who
Michael A. Panzara
Director
Company insider
Files Form 4 as: Director, LeonaBio; Chief Medical Officer, Immunic; Chief Medical Officer, Wave Life Sciences.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $1.7M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 11 Jul 2016
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 24 Apr 2026filed 29 Apr 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 24 Apr 2026filed 29 Apr 2026 | IMUX Immunicoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,900 at $0.00 | filing |
| 24 May 2024filed 24 May 2024 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,900 at $0.00 | filing |
| 19 May 2023filed 22 May 2023 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,900 at $0.00 | filing |
| 25 Jul 2022filed 27 Jul 2022 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 20 May 2022filed 27 May 2022 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —2,311 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $29K16,714 at $1.72 | filing |
| 4 May 2022filed 6 May 2022 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 18 Mar 2022filed 21 Mar 2022 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —27,742 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $24K10,603 at $2.31 | filing |
| 1 Jan 2022filed 4 Jan 2022 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $31K2,929 at $10.57 | filing |
| 1 Feb 2021filed 18 Feb 2021 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Feb 2021filed 18 Feb 2021 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Mar 2020filed 5 Mar 2020 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Michael A. Panzara; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.